J. Erika Haydu

Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas

Teresa Palomero, Lucile Couronné, Hossein Khiabanian et al. · Nature Genetics · 2014 · 601 citations · Full text

Lymphoid Neoplasia, Recurrent Mutations, Somatic Variant +10

Physiological Jak2V617F Expression Causes a Lethal Myeloproliferative Neoplasm with Differential Effects on Hematopoietic Stem and Progenitor Cells

Ann Mullally, Steven Lane, Brian Ball et al. · Cancer Cell · 2010 · 384 citations · Full text

Progenitor Cells, Hematological Malignancy, Medicine +13

<i>ETV6</i> mutations in early immature human T cell leukemias

Pieter Van Vlierberghe, Alberto Ambesi‐Impiombato, Arianne Pérez-García et al. · The Journal of Experimental Medicine · 2011 · 211 citations · Full text

Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in T cell acute lymphoblastic leukemia

Daniel Herranz, Alberto Ambesi‐Impiombato, Jessica Sudderth et al. · Nature Medicine · 2015 · 207 citations · Full text

Hematological Malignancy, Anti-notch1 Therapies, Metabolic Reprogramming +12

Niche-based screening identifies small-molecule inhibitors of leukemia stem cells

Kimberly A. Hartwell, Peter G. Miller, Siddhartha Mukherjee et al. · Nature Chemical Biology · 2013 · 108 citations · Full text

Hematological Malignancy, Mixed-phenotype Acute Leukemia, Stem Cell Research +6